77 related articles for article (PubMed ID: 6253346)
41. Nasopharyngeal and adjacent neoplasms: a clinico-pathologic and immunologic study.
Uhlmann C; Krueger GR; Sesterhenn K; Rose KG; Ablashi DV; Wustrow F
Arch Otorhinolaryngol; 1978 Jan; 218(3-4):163-77. PubMed ID: 305242
[TBL] [Abstract][Full Text] [Related]
42. [A study of HIA-DR antigen expression in nasopharyngeal carcinoma and its relation with clinical pathology and prognosis].
Liu B; Su Z; Chen S
Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):162-4. PubMed ID: 9275672
[TBL] [Abstract][Full Text] [Related]
43. Histopathological and immunological studies of nasopharyngeal carcinoma.
Sawaki S; Sugano H; Hirayama T; Kawamura A; Tachibana T
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Jun; 8(2):73-81. PubMed ID: 1243122
[TBL] [Abstract][Full Text] [Related]
44. Antibody-dependent cellular cytotoxicity. Relation to stage and disease course in North American patients with nasopharyngeal carcinoma.
Neel HB; Pearson GR; Taylor WF
Arch Otolaryngol; 1984 Nov; 110(11):742-7. PubMed ID: 6487126
[TBL] [Abstract][Full Text] [Related]
45. Immunologic detection of occult primary cancer of the head and neck.
Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH
Otolaryngol Head Neck Surg; 1981; 89(2):230-4. PubMed ID: 6264367
[TBL] [Abstract][Full Text] [Related]
46. Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma.
Chan SH; Chew TS; Goh EH; Simons MJ; Shanmugaratnam K
Int J Cancer; 1976 Aug; 18(2):139-44. PubMed ID: 955740
[TBL] [Abstract][Full Text] [Related]
47. Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma.
Galili U; Klein E; Klein G; Singh Bal I
Int J Cancer; 1980 Jan; 25(1):85-9. PubMed ID: 6249765
[TBL] [Abstract][Full Text] [Related]
48. Response to and concentration of interleukin-2 in patients with nasopharyngeal carcinoma.
Hsu MM; Hsu LW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Aug; 22(3):181-5. PubMed ID: 2605977
[TBL] [Abstract][Full Text] [Related]
49. Correlation of tumor burden with in vitro lymphocyte reactivity and antibodies to herpesvirus tumor-associated antigens in head and neck squamous carcinoma.
Silverman NA; Alexander JC; Hollinshead AC; Chretien PB
Cancer; 1976 Jan; 37(1):135-40. PubMed ID: 174796
[TBL] [Abstract][Full Text] [Related]
50. Nasopharyngeal carcinoma. Brief review.
Fedder M; Gonzalez MF
Am J Med; 1985 Sep; 79(3):365-9. PubMed ID: 2994473
[TBL] [Abstract][Full Text] [Related]
51. Lymphocyte subpopulations and mitogenic responses in nasopharyngeal carcinoma, prior to and after radiotherapy.
Lamelin JP; Ellouz R; De Thé G; Revillard JP
Int J Cancer; 1977 Nov; 20(5):723-8. PubMed ID: 200572
[TBL] [Abstract][Full Text] [Related]
52. Immunologic reactivity in patients with nasopharyngeal carcinoma.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Huang SC; Tu SM
Otolaryngol Head Neck Surg; 1980; 88(4):384-90. PubMed ID: 6821420
[TBL] [Abstract][Full Text] [Related]
53. Detection of S-100 labelled cells in nasopharyngeal carcinoma.
Lauriola L; Michetti F; Sentinelli S; Cocchia D
J Clin Pathol; 1984 Nov; 37(11):1235-8. PubMed ID: 6389603
[TBL] [Abstract][Full Text] [Related]
54. The etiology of nasopharyngeal carcinoma.
de Thé G
Pathobiol Annu; 1972; 2():235-54. PubMed ID: 4589746
[No Abstract] [Full Text] [Related]
55. Characterization of a murine monoclonal-antibody-defined B-lymphocyte carcinoma cross-reacting antigen (BLCa) from nasopharyngeal carcinoma tissues.
Yip TC; Chan KH; Choy D; Chan CW; Ng MH
Int J Cancer; 1987 Apr; 39(4):449-51. PubMed ID: 3493980
[TBL] [Abstract][Full Text] [Related]
56. Role of immunohistochemistry in diagnosis of nasopharyngeal tumours.
Bosq J; Gatter KC; Micheau C; Mason DY
J Clin Pathol; 1985 Aug; 38(8):845-8. PubMed ID: 4031096
[TBL] [Abstract][Full Text] [Related]
57. In vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytes.
Ng WS; Ng MH; Ho HC; Lamelin JP
Br J Cancer; 1977 Dec; 36(6):713-22. PubMed ID: 597472
[TBL] [Abstract][Full Text] [Related]
58. Isoantigens A, B, H(O) in nasopharyngeal carcinoma.
Gupta RK
Cancer; 1983 Jan; 51(2):256-9. PubMed ID: 6821815
[TBL] [Abstract][Full Text] [Related]
59. [Cellular immunity in nasopharyngeal carcinoma cases].
Tsukuda M; Tamamushi N; Mochimatsu I; Mitarai K; Sawaki S
Nihon Jibiinkoka Gakkai Kaiho; 1986 Jan; 89(1):7-13. PubMed ID: 3486262
[No Abstract] [Full Text] [Related]
60. [Immunologic study on nasopharyngeal carcinoma patients: correlation of mononuclear cell reactivity to phytohemagglutinin and clinical stage].
Hsu MM; Lin BL
Taiwan Yi Xue Hui Za Zhi; 1983 Sep; 82(9):972-6. PubMed ID: 6581269
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
